Loading, please wait...
Date: Jun 18, 2025 07:00 AM - 08:00 AM
Fee
$0.00
CE Hours
2.00
CE Units
0.200
Registration closes on Jun 20, 2025 11:00 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
|
WellStar Health System is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Participants who attend the entire activity, complete and pass the post-test (>70%) and complete the activity evaluation will receive CE credit.
Credit will be uploaded electronically and be available in CPE Monitor after completion of required elements.
Support/Credits
No commerical support.
Objectives
- 1. Describe the mechanism of action and pharmacologic effects of GLP-1 receptor agonists.
- 2. Differentiate GLP-1 RAs based on their FDA-approved indications for type 2 diabetes, weight management, and cardiovascular benefit, sleep apnea, and renal disease.
- 3. Identify common and serious adverse effects associated with GLP-1 RA therapy and appropriate counseling strategies.
- 4. Identify off-label and potential future uses of GLP-1 RAs in conditions such as NASH, heart failure, sleep apnea and neurodegenerative diseases
Speaker(s)/Author(s)
|
Aana Hampton-Ashford, PharmD
|
Activity Number
0483-0000-25-013-L01-P
Date:
06/18/25
Time:
07:00 AM - 08:00 AM
CE Hours
1.00
Location
via MS Teams and KH
Objectives
- 1. List the brand and generic names of commonly used GLP-1 receptor agonists based on their indications.
- 2. Identify common dosage forms, storage requirements, and administration considerations for GLP-1 RAs.
Speaker(s)/Author(s)
|
Aana Hampton-Ashford, PharmD
|
Activity Number
0483-0000-25-013-L01-T
Date:
06/18/25
Time:
07:00 AM - 08:00 AM
CE Hours
1.00
Location
via MS Teams and KH